HESTER BIOSCIENCES
Back to Cashflow Statement
|
HESTER BIOSCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-52 Cr | ₹-26 Cr | ₹42 Cr | ₹112 Cr | ₹-18 Cr |
What is the latest Cash Flow from Financing Activities ratio of HESTER BIOSCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-52 Cr |
| Mar2024 | ₹-26 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹112 Cr |
| Mar2021 | ₹-18 Cr |
How is Cash Flow from Financing Activities of HESTER BIOSCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-52 Cr | Negative | |
| Mar2024 | ₹-26 Cr | Negative | |
| Mar2023 | ₹42 Cr | -62.56 | |
| Mar2022 | ₹112 Cr | Positive | |
| Mar2021 | ₹-18 Cr | - | |
Compare Cash Flow from Financing Activities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,225.2 Cr | -2.9% | -6.9% | -0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -2.9% |
-6.9% |
-0.1% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses